Qian Liu is a fintech operator and data scientist who helped build the robo investing movement from the inside. A computer scientist by training - PhD in machine learning from Penn, BS from Tsinghua - she was an early member of the Wealthfront founding team and its Director of Research, then Head of Data at GoFundMe, then Chief Data Officer at Guideline, the small-business 401(k) platform. When Gusto acquired Guideline, she moved into a leadership role at Gusto, where the brokerage entity sits inside its HR, payroll and benefits platform serving small and medium businesses. In 2024 she co-authored 'The Little Book of Robo Investing' with Elizabeth MacBride, turning a decade of building automated investing products into a plain-spoken guide for ordinary savers.
Yuanyuan Xu is a structural biologist turned biotech founder who left the protein-crystallography bench at Tsinghua and Yale to build Cure Genetics (克睿基因), a Suzhou clinical-stage company chasing cell and gene therapies for solid tumors and genetic disease. She founded it in 2016, raised a $60M Series B in 2021, and bets on two homegrown platforms: an invariant-natural-killer-T cell therapy (AIMS CAR-NKT) and a directed-evolution engine for new AAV capsids (VELP).
Tim Shi is the co-founder and former CTO of Cresta, the AI platform for contact centers that grew to over $100M ARR and raised $401M from Sequoia, a16z, and Greylock. A Tsinghua CS graduate who did early AI research at OpenAI alongside Andrej Karpathy — including the 'World of Bits' paper on web-based reinforcement learning agents — he co-founded Cresta in 2017 with Zayd Enam after both dropped out of Stanford's AI PhD program. In 2025, he co-founded Recursive Superintelligence, which emerged from stealth with $650M at a $4.65B valuation to build self-improving AI systems.
Sheng Liu is the CEO of TeraHop and co-founder of InnoLight Technology (now Zhongji Innolight), a company that commands over half the global market share in 800G optical transceivers. A PhD from Georgia Tech, he returned to China in 2008 to fill a domestic gap in high-end optical modules, built InnoLight into a global leader across 400G, 800G, and 1.6T products, and now leads TeraHop - backed by Temasek and ADIA - to power the optical backbone of AI infrastructure worldwide.
Yongwei Zhang is the CEO of Complete Genomics and MGI Americas, leading one of the most ambitious efforts to make whole-genome sequencing fast, accurate, and affordable at scale. With a PhD in Mechanical Engineering from Johns Hopkins and dual bachelor's degrees from Tsinghua University, Zhang brings a rare blend of optics precision, software fluency, and entrepreneurial grit to the genomics frontier. He architected the DNBSEQ sequencing platform series now used by over 2,600 researchers in 100 countries, and has positioned Complete Genomics as a formidable challenger to Illumina's market dominance - at a fraction of the cost.
Yinan Na (also known as Steven) is the co-founder and CEO of Creatify AI, an AI-powered video ad platform that lets marketers produce, test, and optimize short-form video ads in minutes. Built on a decade of engineering at Meta and Snap, Creatify crossed $9M ARR within 18 months of launch, raised a $15.5M Series A co-led by Jeffrey Katzenberg's WndrCo, and now serves over 1 million marketers across 10,000+ teams including Alibaba.com, Comcast, and Binance. Na holds a Master's in Computer Science from Stanford and a Bachelor's in Automation from Tsinghua University.
Enhao Gong is the CEO and co-founder of Subtle Medical, a Stanford-born AI healthcare company that has earned 9 FDA clearances for deep learning-powered medical imaging products. A PhD graduate from Stanford in Electrical Engineering, Gong co-founded Subtle Medical in 2017 alongside Stanford neuroradiologist Dr. Greg Zaharchuk, and has grown the company to serve 1,000+ scanner installations globally, touching 2.5 million patients annually. Before Subtle Medical, he co-founded Polarr, an AI photo-editing startup used by tens of millions. He has been recognized by Forbes 30 Under 30 (China/APAC, 2018), Fortune 40 Under 40, and Radiology Business 40 Under 40 (2024), and led Subtle Medical to TIME's World's Top HealthTech Companies list in 2025.